Press release
Nucleic Acid Therapeutics Market (2025) | mRNA Vaccines, siRNA Drugs, Gene Therapy & Biotech Investment Opportunities, & Global Market Insights
Nucleic Acid Therapeutics Market Size 2025
Download Free Sample Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/nucleic-acid-therapeutics-market?kb
nucleic acid therapeutics market continues to evolve rapidly, driven by advances in gene therapy, RNA-based drugs, and targeted delivery systems addressing rare, genetic, and chronic diseases globally.
United States: Recent Industry Developments
✅ February 2026: Ionis Pharmaceuticals advanced its antisense oligonucleotide (ASO) pipeline with novel therapies targeting rare neurological disorders.
✅ January 2026: Alnylam Pharmaceuticals announced progress in RNAi therapeutics for cardiovascular diseases, expanding clinical trial programs.
✅ December 2025: Biogen enhanced research collaborations focused on nucleic acid-based treatments for neurodegenerative diseases.List of Key Players 2026: AAA
Growth Forecast Projected 2026:
The Global Nucleic Acid Therapeutics Market is anticipated to rise at a considerable rate during the forecast period, between 2026 and 2033. In 2025, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Key Developments 2025-2026:
✅ February 2026: Companies expanded clinical trials for mRNA-based therapies and antisense oligonucleotides, targeting rare genetic disorders and improving treatment efficacy with novel delivery platforms.
✅ January 2026: Major biotech firms enhanced RNA interference (RNAi) and siRNA pipelines, integrating lipid nanoparticle and conjugation technologies to optimize tissue-specific delivery and reduce off-target effects.
✅ December 2025: Accelerated adoption of CRISPR/Cas-based gene-editing therapies enabled next-generation therapeutics for oncology and inherited diseases, with improved precision and safety profiles.
✅ November 2025: Strategic collaborations and licensing agreements increased, allowing rapid expansion of nucleic acid therapeutic portfolios and access to advanced manufacturing and clinical capabilities.
✅ October 2025: Regulatory approvals progressed globally for first-in-class oligonucleotide drugs, expanding patient access to innovative therapies for previously untreatable conditions.
How Our Market Research Process Works:
The global Nucleic Acid Therapeutics Market research report is developed using a comprehensive combination of primary and secondary data sources. The study evaluates a wide range of industry-influencing factors, including government regulations, evolving market dynamics, competitive intensity, and historical performance trends. It also analyzes technological advancements, emerging innovations, and developments across related industries. In addition, the report assesses market volatility, growth opportunities, potential barriers, and key challenges that could impact the future expansion of the Nucleic Acid Therapeutics ecosystem.
Recent Mergers & Acquisitions (M & A) 2025-2026:
• March 2026 - Moderna agrees to settle litigation with Arbutus Biopharma & Genevant Sciences, with up to $2.25 billion total payments, resolving global disputes over LNP/mRNA delivery technology and removing future royalty obligations on key mRNA products/comirnaty‐related portfolio.
• March 2026 - Novartis completes acquisition of Avidity Biosciences (focused on RNA‐based antibody oligonucleotide conjugate therapies), in an approx $12 billion deal, integrating Avidity's late‐stage RNA programs and delivery platform into Novartis's pipeline.
• January 2026 - Acuitas Therapeutics takes a majority stake in RNA Technologies & Therapeutics (RNA construct design/optimization specialist), expanding RNA‐LNP delivery and therapeutic capabilities through strategic investment to scale operations for next‐gen RNA therapeutics.
• January 2026 - BioNTech's acquisition of CureVac closes, bringing CureVac's mRNA design, delivery and manufacturing assets together with BioNTech's platform to strengthen mRNA‐based oncology and infectious disease programs (deal valuation ~USD 1.25 billion in stock).
Request Strategic Market Customization: https://datamintelligence.com/customize/nucleic-acid-therapeutics-market?kb
Japan: Recent Industry Developments
✅ February 2026: Daiichi Sankyo developed next-generation mRNA therapeutics for oncology applications.
✅ January 2026: Astellas Pharma advanced nucleic acid therapies targeting rare genetic disorders, focusing on delivery system innovations.
✅ December 2025: Takeda Pharmaceutical Company collaborated with biotech partners to accelerate clinical development of RNA-targeted therapeutics.
Major Focused Key Segmentations 2026:
By category: Antisense Oligonucleotides (ASOs), Small Interfering RNA (siRNA), Messenger RNA (mRNA), Self-Amplifying RNA (saRNA)
By Application: Cancers, Viral Infections, Genetic Disorders, Others
By end-user: Hospitals, Academic & Research Institutes
Regional Growth Analysis for Market:
⇥ North America: Leads the market, driven by strong R&D infrastructure, biotech investments, and extensive clinical trials.
⇥ Japan: Significant presence supported by advanced healthcare infrastructure and increasing adoption of nucleic acid therapies.
⇥ Europe: Growing demand fueled by regulatory support, biotech innovation hubs, and government-backed healthcare initiatives.
⇥ Asia-Pacific (excluding Japan): Rapidly expanding market, led by China, India, and Southeast Asia's large-scale biotech development and therapeutic adoption.
⇥ Middle East & Africa: Emerging opportunities from increasing healthcare investments and adoption of advanced therapies.
We Provide Benefits of the Report:
Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.
Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.
Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.
Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.
Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.
Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.
Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.
Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.
Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.
Unlock Full 360° Strategic Report: https://www.datamintelligence.com/buy-now-page?report=nucleic-acid-therapeutics-market?kb
FAQ
Q1: What is the current size of the Nucleic Acid Therapeutics Market?
A: The Nucleic Acid Therapeutics Market was valued at US$ 5.64 billion in 2024 and is forecasted to hit US$ 14.42 billion by 2032
Q2: How rapidly will the Market expanding?
A: The Nucleic Acid Therapeutics market is projected to grow at a CAGR of 10.9% between 2025 and 2032.
Get Unlimited Market Reports & Strategic Insights: https://www.datamintelligence.com/reports-subscription?kb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nucleic Acid Therapeutics Market (2025) | mRNA Vaccines, siRNA Drugs, Gene Therapy & Biotech Investment Opportunities, & Global Market Insights here
News-ID: 4435398 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Vaccine Packaging Market 2026, driven by expanding immunization programs and col …
Leander Texas-
Vaccine Packaging Market reached US$ 1.3 billion in 2022 and is expected to reach US$ 2.9 billion by 2030, growing with a CAGR of 13.2% during the forecast period 2023-2030.
DataM Intelligence has released a new research report titled "Vaccine Packaging Market Size 2026" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players.…
Anti-Slip Additives Market (2026) | Polymer Coatings, Surface Protection, Safety …
DataM Intelligence has released a new research report titled "Anti-Slip Additives Market Size 2026" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms…
High-Performance Fluoropolymers Market to grow at 6% CAGR | Leading Companies 20 …
"The high-performance fluoropolymers market is growing at a CAGR of 6% during the forecast period (2024-2031)."
DataM Intelligence unveils exclusive insights into the High-Performance Fluoropolymers Market 2026, highlighting emerging trends, growth drivers, and key regional opportunities worldwide. The report helps solve critical business challenges by identifying high-growth segments and reducing investment risks through actionable forecasts. With in-depth competitive benchmarking, it enables smarter strategies and confident decision-making.
Download your exclusive sample report today:…
Drone Battery Swapping Market to Hit US$ 13.9 Billion by 2031 | Leading Companie …
"Global Drone Battery Swapping Market reached US$ 12.5 billion in 2022 and is expected to reach US$ 13.9 billion by 2031, growing with a CAGR of 4.4% during the forecast period 2024-2031."
DataM Intelligence unveils exclusive insights into the Drone Battery Swapping Market 2026, highlighting emerging trends, growth drivers, and key regional opportunities worldwide. The report helps solve critical business challenges by identifying high-growth segments and reducing investment risks through actionable…
More Releases for RNA
United States Lead Small Interfering RNA (siRNA) Therapeutics Market at 17.4% CA …
Leander, Texas and Tokyo, Japan - Jan.08.2026
As per DataM Intelligence research report "Small Interfering RNA (siRNA) Therapeutics Market reached US$ 2.55 billion in 2024 and is expected to reach US$ 12.38 billion by 2033, growing with a CAGR of 17.4% from 2025 to 2033." Rising research and development activities, regulatory approvals, demand for targeted therapies against chronic and rare diseases, and advancements in delivery technologies are fueling growth in the…
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
